Novartis | NVS - Costo Del Venduto

Prezzo Delle Azioni
143.01
Cambio Giornaliero
-2.43 -1.67%
Mensile
-4.90%
Annuale
26.22%
Q2 Previsione
142.62




Costo Del Venduto Cambiamento Data
AbbVie USD 4.22B 329M 2026-03
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Bausch Health Companies USD 1.03B 284M 2025-12
Biogen USD 797.5M 302M 2026-03
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Glaxosmithkline GBP 3.47B 461.37M 2025-12
J&J USD 8.07B 103M 2026-03
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 3M 2025-12
Novartis USD 3.54B 7M 2025-12
Pacira USD 54.62M 6.02M 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Sanofi EUR 3.76B 344M 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Zoetis USD 743M 60M 2025-12